Concepedia

Samuel M. Niman

SM

Statistics

Publications

9

Citations

406

H-Index

9

Active since

2020

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Hospital Zambrano Hellion

Tecnológico de Monterrey

International Breast Cancer Study Group

Samuel M. Niman is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and hormone receptor-positive breast cancer therapy.

Publications per year

2020–2025

9

Publications

9

Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer

Ann H. Partridge, Samuel M. Niman, Monica Ruggeri et al. · New England Journal of Medicine · 2023 · 215 citations · Full text

, , +17

Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy

Ann H. Partridge, Samuel M. Niman, Monica Ruggeri et al. · The Breast · 2021 · 55 citations · Full text

, , +15

Fertility Preservation and Assisted Reproduction in Patients With Breast Cancer Interrupting Adjuvant Endocrine Therapy to Attempt Pregnancy

Hatem A. Azim, Samuel M. Niman, Ann H. Partridge et al. · Journal of Clinical Oncology · 2024 · 27 citations · Full text

, , +17

Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients

Costanza Paoletti, Meredith M. Regan, Samuel M. Niman et al. · npj Breast Cancer · 2021 · 26 citations · Full text

, , +17

Plasma Kidney Injury Molecule-1 for Preoperative Prediction of Renal Cell Carcinoma Versus Benign Renal Masses, and Association With Clinical Outcomes

Wenxin Xu, Valérie Gaborieau, Samuel M. Niman et al. · Journal of Clinical Oncology · 2024 · 25 citations · Full text

, , +17

1–5 of 9